Calamos Advisors’s DNA X Inc SONM Stock Holding History

Calamos Advisors’s Portfolio SONM Stock Details SONM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-51	Closed	-$1.16M	–	796
2019 Q2	$1.16M	Buy	+51	New	+$1.29M	0.01%	639

Other funds holding SONM

Nokomis Capital Dallas, Texas $349M AUM 75.66% 1-Year Est. Return

BRF

B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

Alambic Investment Management Belvedere, California $9.12M AUM 34.54% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return

Calamos Advisors's SONM Position: Q3 2019 in Review

Calamos Advisors sold out of DNA X Inc (SONM) in Q3 2019, closing a stake of 51 shares — an estimated $1.16M sold.

Calamos Advisors first reported a position in SONM in Q2 2019 and held it in 1 quarter. The position peaked at $1.16M in Q2 2019. 33 funds tracked by Wall St. Rank hold SONM as of Q3 2019.

Calamos Advisors reported no remaining DNA X Inc position as of Q3 2019 after selling out during the quarter.
Calamos Advisors sold 51 DNA X Inc shares in Q3 2019, an estimated $1.16M.
Calamos Advisors first reported a position in DNA X Inc in Q2 2019 and held it in 1 quarter.
Calamos Advisors's DNA X Inc position peaked at $1.16M in Q2 2019.
33 funds tracked by Wall St. Rank held DNA X Inc as of Q3 2019.

Based on Calamos Advisors's 13F filing for Q3 2019, filed 21 Oct 2019.